Rock Springs Capital Management’s Exact Sciences EXAS Stock Holding History

Rock Springs Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-601,800	Closed	-$61.1M	–	102
2025 Q4	$61.1M	Buy	601,800 +8,300	+1%	+$667K	3.13%	7
2025 Q3	$32.5M	Buy	593,500 +21,500	+4%	+$1.07M	1.9%	18
2025 Q2	$30.4M	Buy	572,000 +92,000	+19%	+$4.67M	1.89%	20
2025 Q1	$20.8M	Buy	480,000 +30,000	+7%	+$1.52M	1.19%	30
2024 Q4	$25.3M	Sell	450,000 -697,500	-61%	-$43.4M	0.96%	36
2024 Q3	$78.2M	Buy	1,147,500 +66,000	+6%	+$3.72M	2.54%	7
2024 Q2	$45.7M	Buy	1,081,500 +21,750	+2%	+$1.2M	1.38%	28
2024 Q1	$73.2M	Buy	1,059,750 +40,250	+4%	+$2.55M	1.86%	17
2023 Q4	$75.4M	Buy	1,019,500 +1,250	+0.1%	+$81.9K	1.86%	17
2023 Q3	$69.5M	Buy	1,018,250 +74,750	+8%	+$6.34M	1.86%	16
2023 Q2	$88.6M	Buy	943,500 +2,000	+0.2%	+$156K	2.11%	14
2023 Q1	$63.8M	Buy	941,500 +54,000	+6%	+$3.47M	1.52%	21
2022 Q4	$43.9M	Buy	887,500 +308,900	+53%	+$12.6M	1.06%	35
2022 Q3	$18.8M	Buy	578,600 +5,900	+1%	+$243K	0.49%	57
2022 Q2	$22.6M	Buy	572,700 +2,700	+0.5%	+$144K	0.66%	46
2022 Q1	$39.9M	Hold	570,000	–	–	1%	34
2021 Q4	$44.4M	Hold	570,000	–	–	1.03%	33
2021 Q3	$54.4M	Hold	570,000	–	–	1.14%	29
2021 Q2	$70.9M	Hold	570,000	–	–	1.4%	19
2021 Q1	$75.1M	Buy	570,000 +85,000	+18%	+$11.6M	1.64%	19
2020 Q4	$64.3M	Buy	485,000 +61,000	+14%	+$7.38M	1.36%	20
2020 Q3	$43.2M	Hold	424,000	–	–	1.1%	34
2020 Q2	$36.9M	Hold	424,000	–	–	1.01%	38
2020 Q1	$24.6M	Buy	424,000 +4,000	+1%	+$325K	1.02%	41
2019 Q4	$38.8M	Sell	420,000 -11,750	-3%	-$1.03M	1.23%	23
2019 Q3	$39M	Buy	431,750 +34,750	+9%	+$3.96M	1.55%	18
2019 Q2	$46.9M	Hold	397,000	–	–	1.7%	13
2019 Q1	$34.4M	Buy	397,000 +12,000	+3%	+$1.02M	1.33%	19
2018 Q4	$24.3M	Hold	385,000	–	–	1.15%	25
2018 Q3	$30.4M	Buy	385,000 +5,000	+1%	+$326K	1.1%	27
2018 Q2	$22.7M	Buy	380,000 +9,500	+3%	+$511K	0.87%	36
2018 Q1	$14.9M	Sell	370,500 -64,400	-15%	-$3.14M	0.64%	59
2017 Q4	$22.9M	Sell	434,900 -2,500	-0.6%	-$133K	1.04%	27
2017 Q3	$20.6M	Sell	437,400 -100	-0%	-$4.03K	0.95%	33
2017 Q2	$15.5M	Buy	437,500 +100,000	+30%	+$3.09M	0.78%	47
2017 Q1	$7.97M	Sell	337,500 -113,400	-25%	-$2.25M	0.46%	68
2016 Q4	$6.02M	Buy	450,900 +15,900	+4%	+$257K	0.4%	71
2016 Q3	$8.08M	Buy	+435,000	New	+$7.67M	0.51%	57

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Rock Springs Capital Management's EXAS Position: Q1 2026 in Review

Rock Springs Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 601,800 shares — an estimated $61.1M sold.

Rock Springs Capital Management first reported a position in EXAS in Q3 2016 and held it in 38 quarters. The position peaked at $88.6M in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Rock Springs Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Rock Springs Capital Management sold 601,800 Exact Sciences shares in Q1 2026, an estimated $61.1M.
Rock Springs Capital Management first reported a position in Exact Sciences in Q3 2016 and held it in 38 quarters.
Rock Springs Capital Management's Exact Sciences position peaked at $88.6M in Q2 2023.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Rock Springs Capital Management's 13F filing for Q1 2026, filed 15 May 2026.